Assessing Lead Time Of Selected Ovarian Cancer Biomarkers

Concentrations of the biomarkers CA125, human epididymis 4 (HE4), and mesothelin began to rise 3 years before clinical diagnosis of ovarian , according to a new study published December 30 in the Journal of the National Institute. However, the biomarkers became substantially elevated only in the last year prior to diagnosis…


Read more

Related posts

Leave a Reply